The human gut sterolbiome:bile acid-microbiome endocrine aspects and therapeutics

被引:0
作者
Jason MRidlon [1 ,2 ]
Jasmohan SBajaj [2 ,3 ]
机构
[1] Department of Microbiology and Immunology, Virginia Commonwealth University
[2] McGuire VA Medical Center
[3] Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University
关键词
Sterolbiome; Gut microbiome; Bile acids; Metabolite; Therapeutic agent;
D O I
暂无
中图分类号
R363 [病理生理学];
学科分类号
100104 ;
摘要
The human body is now viewed as a complex ecosystem that on a cellular and gene level is mainly prokaryotic. The mammalian liver synthesizes and secretes hydrophilic primary bile acids, some of which enter the colon during the enterohepatic circulation, and are converted into numerous hydrophobic metabolites which are capable of entering the portal circulation, returned to the liver, and in humans,accumulating in the biliary pool. Bile acids are hormones that regulate their own synthesis, transport, in addition to glucose and lipid homeostasis, and energy balance. The gut microbial community through their capacity to produce bile acid metabolites distinct from the liver can be thought of as an "endocrine organ"with potential to alter host physiology, perhaps to their own favor. We propose the term "sterolbiome" to describe the genetic potential of the gut microbiome to produce endocrine molecules from endogenous and exogenous steroids in the mammalian gut. The affinity of secondary bile acid metabolites to host nuclear receptors is described, the potential of secondary bile acids to promote tumors, and the potential of bile acids to serve as therapeutic agents are discussed.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 22 条
[1]  
Bile acids are nutrient signaling hormones[J] . Huiping Zhou,Phillip B. Hylemon.Steroids . 2014
[2]  
Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficle[J] . Robert A. Britton,Vincent B. Young.Gastroenterology . 2014
[3]  
The bile acid TGR5 membrane receptor: From basic research to clinical application[J] . Henri Duboc,Yvette Taché,Alan F. Hofmann.Digestive and Liver Disease . 2013
[4]   Pleiotropic Roles of Bile Acids in Metabolism [J].
Vallim, Thomas Q. de Aguiar ;
Tarling, Elizabeth J. ;
Edwards, Peter A. .
CELL METABOLISM, 2013, 17 (05) :657-669
[5]  
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist[J] . Sama I. Sayin,Annika Wahlstr?m,Jenny Felin,Sirkku J?ntti,Hanns-Ulrich Marschall,Krister Bamberg,Bo Angelin,Tuulia Hy?tyl?inen,Matej Ore?i?,Fredrik B?ckhed.Cell Metabolism . 2013 (2)
[6]   Contribution of the 7β-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon [J].
Lee, Ja-Young ;
Arai, Hisashi ;
Nakamura, Yusuke ;
Fukiya, Satoru ;
Wada, Masaru ;
Yokota, Atsushi .
JOURNAL OF LIPID RESEARCH, 2013, 54 (11) :3062-3069
[7]   Emerging Role of Fibroblast Growth Factors 15/19 and 21 as Metabolic Integrators in the Liver [J].
Cicione, Claudia ;
Degirolamo, Chiara ;
Moschetta, Antonio .
HEPATOLOGY, 2012, 56 (06) :2404-2411
[8]  
Chemoprevention of colorectal cancer with ursodeoxycholic acid: Pro[J] . Lawrence Serfaty.Clinics and Research in Hepatology and Gastroenterology . 2012
[9]  
Chemoprevention of colorectal cancer with ursodeoxycholic acid: Cons[J] . Elizabeth J. Carey,Keith D. Lindor.Clinics and Research in Hepatology and Gastroenterology . 2012
[10]  
The Human Microbiome: Our Second Genome[J] . Elizabeth A. Grice,Julia A. Segre.Annual Review of Genomics and Human Genetics . 2012